Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel.
about
Update on Chemotherapy-Induced Peripheral Neuropathy.Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.Novel Strategies on Personalized Medicine for Breast Cancer Treatment: An Update.Assessment of Pharmacogenomic Panel Assay for Prediction of Taxane Toxicities: Preliminary Results.SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand.
P2860
Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polymorphism of CYP3A4 and ABC ...... with paclitaxel and docetaxel.
@en
Polymorphism of CYP3A4 and ABC ...... with paclitaxel and docetaxel.
@nl
type
label
Polymorphism of CYP3A4 and ABC ...... with paclitaxel and docetaxel.
@en
Polymorphism of CYP3A4 and ABC ...... with paclitaxel and docetaxel.
@nl
prefLabel
Polymorphism of CYP3A4 and ABC ...... with paclitaxel and docetaxel.
@en
Polymorphism of CYP3A4 and ABC ...... with paclitaxel and docetaxel.
@nl
P2093
P2860
P356
P1476
Polymorphism of CYP3A4 and ABC ...... with paclitaxel and docetaxel
@en
P2093
Abdullah Tuncay Demiryurek
Alper Sevinc
Celaletdin Camci
Mehmet Emin Kalender
Mustafa Ulasli
Serdar Oztuzcu
P2860
P304
P356
10.2147/OTT.S106574
P407
P50
P577
2016-08-12T00:00:00Z